Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii

International Journal of Antimicrobial Agents

Volumn 46, Issue 6, 2015, Pages 696-702

  García Quintanilla, Meritxell ^a   Carretero Ledesma, Marta ^a   Moreno Martínez, Patricia ^a   Martín Peña, Reyes ^a   Pachón, Jerónimo ^a   McConnell, Michael J ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Acinetobacter baumannii; Antibiotics; Antimicrobial peptides; Colistin resistance; Collateral sensitivity

Indexed keywords

AMIKACIN; AMPICILLIN; AZITHROMYCIN; CECROPIN; CECROPIN A; CECROPIN P1; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; INDOLICIDIN; LIPOPOLYSACCHARIDE; MASTOPARAN; MELITTIN; MELITTIN A; MEROPENEM; RIFAMPICIN; SULBACTAM; TICARCILLIN; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; LIPID A;

ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; CONTROLLED STUDY; EPSILOMETER TEST; GENE MUTATION; LPXA GENE; LPXC GENE; LPXD GENE; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; ACINETOBACTER INFECTIONS; BIOSYNTHESIS; DRUG EFFECTS; GENETICS; HUMAN; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; AZITHROMYCIN; BACTERIAL PROTEINS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; LIPID A; LIPOPOLYSACCHARIDES; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; RIFAMPIN; VANCOMYCIN;

EID: 84949626969     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2015.07.017     Document Type: Article

References (26)

1. M. García-Quintanilla, M.R. Pulido, R. López-Rojas, J. Pachon, and M.J. McConnell Emerging therapies for multidrug resistant Acinetobacter baumannii Trends Microbiol 21 2013 157 163
2. R. López-Rojas, M.E. Jiménez-Mejías, J.A. Lepe, and J. Pachon Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain J Infect Dis 204 2011 1147 1148
3. J.M. Rolain, A. Roch, M. Castanier, L. Papazian, and D. Raoult Acinetobacter baumannii resistant to colistin with impaired virulence: a case report from France J Infect Dis 204 2011 1146 1147
4. R. Valencia, L.A. Arroyo, M. Conde, J.M. Aldana, M.J. Torres, F. Fernández-Cuenca, and et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital Infect Control Hosp Epidemiol 30 2009 257 263
5. M.D. Adams, G.C. Nickel, S. Bajaksouzian, H. Lavender, A.R. Murthy, M.R. Jacobs, and et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system Antimicrob Agents Chemother 53 2009 3628 3634
6. A. Beceiro, E. Llobet, J. Aranda, J.A. Bengoechea, M. Doumith, M. Hornsey, and et al. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system Antimicrob Agents Chemother 55 2011 3370 3379
7. J.H. Moffatt, M. Harper, P. Harrison, J.D. Hale, E. Vinogradov, T. Seemann, and et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production Antimicrob Agents Chemother 54 2010 4971 4977
8. D. Alves, and M. Olivia Pereira Mini-review: antimicrobial peptides and enzymes as promising candidates to functionalize biomaterial surfaces Biofouling 30 2014 483 499
9. X. Vila-Farres, C. García de la Maria, R. López-Rojas, J. Pachon, E. Giralt, and J. Vila In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii Clin Microbiol Infect 18 2011 383 387
10. C. Pál, B. Papp, and V. Lázár Collateral sensitivity of antibiotic-resistant microbes Trends Microbiol 23 2015 401 407
11. L. Leive The barrier function of the Gram-negative envelope Ann N Y Acad Sci 235 1974 109 129
12. H. Nikaido Molecular basis of bacterial outer membrane permeability revisited Microbiol Mol Biol Rev 67 2003 593 656
13. F. Fernández-Cuenca, A. Pascual, A. Ribera, J. Vila, G. Bou, J.M. Cisneros, and et al. Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain. A nationwide multicenter study: GEIH-Ab project (2000) Enferm Infecc Microbiol Clin 22 2004 267 271 [in Spanish]
14. M. García-Quintanilla, M.R. Pulido, P. Moreno-Martínez, R. Martin-Pena, R. López-Rojas, J. Pachon, and et al. Activity of host antimicrobials against multidrug-resistant Acinetobacter baumannii acquiring colistin resistance through loss of lipopolysaccharide Antimicrob Agents Chemother 58 2014 2972 2975
15. I.G. Schaub, and F.D. Hauber A biochemical and serological study of a group of identical unidentifiable Gram-negative bacilli from human sources J Bacteriol 56 1948 379 385
16. M. Fernández-Reyes, M. Rodríguez-Falcon, C. Chiva, J. Pachon, D. Andreu, and L. Rivas The cost of resistance to colistin in Acinetobacter baumannii: a proteomic perspective Proteomics 9 2009 1632 1645
17. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard-ninth edition. Document M07-A9 2012 CLSI Wayne, PA
18. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-fourth informational supplement. Document M100-S24 2014 CLSI Wayne, PA
19. S. Magnet, P. Courvalin, and T. Lambert Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454 Antimicrob Agents Chemother 45 2001 3375 3380
20. L.A. Arroyo, A. Garcia-Curiel, M.E. Pachon-Ibanez, A.C. Llanos, M. Ruiz, J. Pachon, and et al. Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii J Clin Microbiol 43 2005 903 905
21. S. Pournaras, E. Ntokou, O. Zarkotou, K. Ranellou, K. Themeli-Digalaki, C. Stathopoulos, and et al. Linezolid dependence in Staphylococcus epidermidis bloodstream isolates Emerg Infect Dis 19 2013 129 132
22. P.A. Tambyah, J.A. Marx, and D.G. Maki Nosocomial infection with vancomycin-dependent enterococci Emerg Infect Dis 10 2004 1277 1281
23. T. Worthington, J. White, P. Lambert, S. Adlakha, and T. Elliott β-Lactam-dependent coagulase-negative Staphylococcus associated with urinary-tract infection Lancet 354 1999 1097
24. D. Meziane-Cherif, F.A. Saul, C. Moubareck, P. Weber, A. Haouz, P. Courvalin, and et al. Molecular basis of vancomycin dependence in VanA-type Staphylococcus aureus VRSA-9 J Bacteriol 192 2010 5465 5471
25. M. Vaara, and M. Nurminen Outer membrane permeability barrier in Escherichia coli mutants that are defective in the late acyltransferases of lipid A biosynthesis Antimicrob Agents Chemother 43 1999 1459 1462
26. J.S. Hawley, C.K. Murray, and J.H. Jorgensen Development of colistin-dependent Acinetobacter baumannii-Acinetobacter calcoaceticus complex Antimicrob Agents Chemother 51 2007 4529 4530